HCAT
insider transactionsHealth Catalyst, Inc. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
No open-market buys or sells this period. The trades below are grants, option exercises and gifts, which carry no market price.
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Other·F
Benjamin Albert KEY
CEO
$58.3K
34.5K sh · $1.69
Own -2%
-
Other·F
General Counsel
$18.9K
13.8K sh · $1.37
Own -4%
-
Grant·A
Director
$0
12.7K sh
Own +16%
-
Other·F
Chief People Officer
$11.7K
8.5K sh · $1.37
Own -3%
-
Other·F
Jason Alger KEY
Chief Financial Officer
$25.8K
18.8K sh · $1.37
Own -3%
-
Other·F
Benjamin Albert KEY
CEO
$460
336 sh · $1.37
Own -0%
-
Other·F
Benjamin Albert KEY
CEO
$417
310 sh · $1.35
Own -0%
-
Grant·A
Director
$0
154.8K sh
Own New
-
Grant·A
Benjamin Albert KEY
CEO
$0
1.1K sh
Own +0%
-
Other·F
Benjamin Albert KEY
CEO
$130.2K
70.5K sh · $1.85
Own -5%
-
Other·F
General Counsel
$34.6K
20.8K sh · $1.66
Own -5%
-
Other·F
Chief People Officer
$23.0K
13.8K sh · $1.66
Own -4%
-
Other·F
Jason Alger KEY
Chief Financial Officer
$44.8K
27.0K sh · $1.66
Own -4%
-
Other·F
Benjamin Albert KEY
CEO
$8.2K
5.0K sh · $1.66
Own -0%
-
Grant·A
Director
$0
8.4K sh
Own +11%
-
Other·F
General Counsel
$11.0K
6.3K sh · $1.75
Own -2%
-
Other·F
Chief People Officer
$7.8K
4.5K sh · $1.75
Own -1%
-
Other·F
Jason Alger KEY
Chief Financial Officer
$13.1K
7.5K sh · $1.75
Own -1%
-
Other·F
Benjamin Albert KEY
CEO
$23.3K
13.3K sh · $1.75
Own -1%
-
Grant·A
General Counsel
$0
16.5K sh
Own +4%
-
Grant·A
General Counsel
$0
289.0K sh
Own +289%
-
Grant·A
Chief People Officer
$0
13.2K sh
Own +4%
-
Grant·A
Chief People Officer
$0
191.5K sh
Own +134%
-
Grant·A
Jason Alger KEY
Chief Financial Officer
$0
22.2K sh
Own +3%
-
Grant·A
Jason Alger KEY
Chief Financial Officer
$0
507.5K sh
Own +206%
-
Grant·A
Benjamin Albert KEY
CEO
$0
38.8K sh
Own +3%
-
Grant·A
Benjamin Albert KEY
CEO
$0
930.0K sh
Own +161%
-
Grant·A
Director
$0
7.6K sh
Own +6%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 10, 2026 | Benjamin Albert KEY | Other F | 34.5K | $58.3K |
| Jun 1, 2026 | Benjamin Landry | Other F | 13.8K | $18.9K |
| Jun 1, 2026 | Julie Larson-Green | Grant A | 12.7K | $0 |
| Jun 1, 2026 | Linda Llewelyn | Other F | 8.5K | $11.7K |
| Jun 1, 2026 | Jason Alger KEY | Other F | 18.8K | $25.8K |
| Jun 1, 2026 | Benjamin Albert KEY | Other F | 336 | $460 |
| May 1, 2026 | Benjamin Albert KEY | Other F | 310 | $417 |
| May 1, 2026 | Steven H Nelson | Grant A | 154.8K | $0 |
| Apr 29, 2026 | Benjamin Albert KEY | Grant A | 1.1K | $0 |
| Mar 10, 2026 | Benjamin Albert KEY | Other F | 70.5K | $130.2K |
| Mar 2, 2026 | Benjamin Landry | Other F | 20.8K | $34.6K |
| Mar 2, 2026 | Linda Llewelyn | Other F | 13.8K | $23.0K |
| Mar 2, 2026 | Jason Alger KEY | Other F | 27.0K | $44.8K |
| Mar 2, 2026 | Benjamin Albert KEY | Other F | 5.0K | $8.2K |
| Mar 1, 2026 | Julie Larson-Green | Grant A | 8.4K | $0 |
| Feb 26, 2026 | Benjamin Landry | Other F | 6.3K | $11.0K |
| Feb 26, 2026 | Linda Llewelyn | Other F | 4.5K | $7.8K |
| Feb 26, 2026 | Jason Alger KEY | Other F | 7.5K | $13.1K |
| Feb 26, 2026 | Benjamin Albert KEY | Other F | 13.3K | $23.3K |
| Feb 25, 2026 | Benjamin Landry | Grant A | 16.5K | $0 |
| Feb 25, 2026 | Benjamin Landry | Grant A | 289.0K | $0 |
| Feb 25, 2026 | Linda Llewelyn | Grant A | 13.2K | $0 |
| Feb 25, 2026 | Linda Llewelyn | Grant A | 191.5K | $0 |
| Feb 25, 2026 | Jason Alger KEY | Grant A | 22.2K | $0 |
| Feb 25, 2026 | Jason Alger KEY | Grant A | 507.5K | $0 |
| Feb 25, 2026 | Benjamin Albert KEY | Grant A | 38.8K | $0 |
| Feb 25, 2026 | Benjamin Albert KEY | Grant A | 930.0K | $0 |
| Feb 17, 2026 | Duncan Gallagher | Grant A | 7.6K | $0 |
About HCAT insider trading
This page tracks insider transactions for Health Catalyst, Inc. (HCAT) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.